SARAH ENCHAUTEGUI: Open Payments
NPI 1538840897 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 74 payments from 18 companies in 2025. Trend: 2023 $301 · 2024 $525 · 2025 $1,564
Food & beverage: $1,564
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $241 |
| ABBVIE INC. | 12 | $213 |
| Janssen Pharmaceuticals, Inc | 9 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $150 |
| Teva Pharmaceuticals USA, Inc. | 4 | $109 |
| Corium, LLC | 4 | $107 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Braeburn Inc. | 3 | $79 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
Products named: COBENFY, VRAYLAR, CAPLYTA, REXULTI, Azstarys, Auvelity, INVEGA SUSTENNA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
